Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives
The tumor necrosis factor superfamily (TNFSF) and their receptors (TNFRSF) are important regulators of the immune system, mediating proliferation, survival, differentiation, and function of immune cells. As a result, their targeting for immunotherapy is attractive, although to date, under-exploited....
Main Authors: | Osman Dadas, Ayse Ertay, Mark S. Cragg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1147467/full |
Similar Items
-
O TRÁGICO E O AGÓN EM NIETZSCHE
by: Thiago Mota
Published: (2019-03-01) -
O TRÁGICO E O AGÓN EM NIETZSCHE
by: Thiago Mota Fontenele e Silva
Published: (2021-07-01) -
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
by: Joaquim Azevedo Neto, et al.
Published: (2020-08-01) -
Agonal Thrombus at Necropsy—A Third Category of Blood Coagulation in Domestic Carnivores
by: Raluca Elena Tiu, et al.
Published: (2023-08-01) -
Video characteristics for remote recognition of agonal respiration: A pilot study
by: Kai-Wei Lin, et al.
Published: (2023-09-01)